Evidence map›Paper›PMID 29808017›Full record

ArticleBritish journal of cancer2018

High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.

Päivi Sirniö, Anne Tuomisto, Taina Tervahartiala, Timo Sorsa, Kai Klintrup, Toni Karhu, Karl-Heinz Herzig, Jyrki Mäkelä, Tuomo J Karttunen, Tuula Salo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. The MMPBiomolecules · 2019
    Pooled it
  2. The Role of MMP8 in Cancer: A Systematic Review.International journal of molecular sciences · 2019
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Päivi SirniöCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland.
Anne TuomistoCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland.
Taina TervahartialaDepartment of Oral and Maxillofacial Diseases, University of Helsinki, Haartmaninkatu 8, POB 63, 00014, Helsinki, Finland.
Timo SorsaDepartment of Oral and Maxillofacial Diseases, University of Helsinki, Haartmaninkatu 8, POB 63, 00014, Helsinki, Finland.
Kai KlintrupOulu University Hospital and Medical Research Center Oulu, POB 21, 90029, Oulu, Finland.
Toni KarhuResearch Unit of Biomedicine and Biocenter Oulu, Department of Physiology, University of Oulu, POB 5000, 90014, Oulu, Finland.
Karl-Heinz HerzigOulu University Hospital and Medical Research Center Oulu, POB 21, 90029, Oulu, Finland.
Jyrki MäkeläOulu University Hospital and Medical Research Center Oulu, POB 21, 90029, Oulu, Finland.
Tuomo J KarttunenCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland.
Tuula SaloCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland.
Markus J MäkinenCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland.
Juha P VäyrynenCancer and Translational Medicine Research Unit, University of Oulu, POB 5000, 90014, Oulu, Finland. juha.vayrynen@oulu.fi.ORCID http://orcid.org/0000-0002-8683-2996
Oulu University Hospital · FIUniversity of Helsinki · FIPoznan University of Medical Sciences · PLUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMatrix metalloproteinase-8 (MMP-8) is a protease mainly expressed by neutrophils that cleaves numerous substrates, including collagens and cytokines. We have previously shown that serum MMP-8 levels increase in colorectal cancer (CRC) and correlate with distant metastasis. However, short follow-up in our prospective cohort did not enable survival analyses at the time of the first publication.

methodsPreoperative serum MMP-8 levels were measured by immunofluorometric assay in 271 CRC patients and related to clinicopathological parameters, markers of systemic inflammation (modified Glasgow Prognostic Score, mGPS; serum levels of C-reactive protein (CRP), albumin and 13 cytokines), the density of six types of tumour-infiltrating immune cells and survival.

resultsIncreased MMP-8 levels associated with higher mGPS and higher serum levels of CRP and several cytokines, including IL-1ra, IL-7 and IL-8 (p < 0.001 for all). Serum MMP-8 negatively correlated with tumour-infiltrating mast cells (invasive margin: p = 0.005, tumour centre: p = 0.010). The patients with high-serum MMP-8 levels (>100 ng/mL) had poor cancer-specific survival, independent of tumour stage, grade, lymphatic invasion, patient age, BRAF VE1 immunohistochemistry, mismatch repair deficiency, Immunoscore and mGPS (multivariate HR 2.12, 95% CI 1.21-3.71, p = 0.009).

conclusionsHigh-serum MMP-8 levels are associated with systemic inflammation and adverse outcome in CRC.

Indexed as

AgedBiomarkers, TumorColorectal NeoplasmsC-Reactive ProteinDisease-Free SurvivalFemaleHumansInflammationInterleukin 1 Receptor Antagonist ProteinInterleukin-7Interleukin-8MaleMatrix Metalloproteinase 8Middle AgedNeutrophilsPrognosisBiomarkers, TumorBRAF protein, humanC-Reactive ProteinInterleukin 1 Receptor Antagonist ProteinInterleukin-7Interleukin-8Matrix Metalloproteinase 8Proto-Oncogene Proteins B-raf

Identifiers

PMID29808017
PMCPMC6048114
OpenAlexW2803755039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.